Dr. Richard H. LeConey, MD Joins PranaX Corporation as Chief Medical Officer Leading the Way in Regenerative Medicine

Dr. Richard H. LeConey, MD: New Chief Medical Officer at PranaX Corporation

Overview of Appointment

PranaX Corporation, a prominent player in the field of biotechnology, has made a significant strategic move by appointing Dr. Richard H. LeConey, MD, as its new Chief Medical Officer. This announcement came on April 1, 2026, marking a pivotal moment for the company as it continues to focus on innovative solutions in the realm of regenerative biologics. Dr. LeConey's role is not just a title; he is expected to guide the strategic direction of PranaX’s exosome product portfolio, making him instrumental in the company’s future.

Bringing Expertise to the Table

With a wealth of clinical experience in emergency medicine, preventive care, and regenerative wellness, Dr. LeConey is uniquely qualified for this role. He is the founder of AntiAge MedSpa located in Houston, Texas, where he pioneered patient-centric approaches in longevity, aesthetics, and overall wellness. Dr. LeConey’s advanced medical education, acquired from the University of Texas Medical Branch at Galveston, provides a strong clinical foundation. His focus on evidence-based regenerative treatments will advance PranaX's objectives significantly.

Dr. Steven J. Greco, the Chief Operating Officer of PranaX, commended the appointment by stating, “Richard brings a uniquely comprehensive medical perspective, spanning acute care, preventive medicine, and wellness therapies.” This holistic approach to healthcare marks an exciting phase for PranaX as it strengthens partnerships within the physician community and enhances its clinical impact.

Key Responsibilities

In his new position, Dr. LeConey will oversee the clinical development of PranaX’s product offerings. His responsibilities also include fostering physician education and engagement while ensuring alignment with evolving standards in aesthetic medicine and healthy aging. Given the rapid advancements in medical technologies and methodologies, Dr. LeConey’s leadership in navigating these changes will be crucial.

Vision for the Future

Upon accepting his new role, Dr. LeConey expressed his enthusiasm. He stated, “I am excited to join PranaX at a pivotal time in the evolution of regenerative medicine.” His vision aligns with the company’s mission to focus on scientifically grounded and clinically relevant biologics, which he believes will elevate standards of care.

The PranaX Mission

PranaX aims to unlock the potential of stem cell-derived exosomes through rigorous scientific inquiry. The company is devoted to promoting wellness and guiding individuals toward healthier, more fulfilling lives. Its headquarters are located within the Levit Green Life Sciences campus in Houston, Texas, a hub for biotechnology innovation and research. By focusing on this path, PranaX is taking significant strides in the field of regenerative medicine, ensuring a healthier future for many.

Conclusion

Dr. Richard H. LeConey's appointment as Chief Medical Officer at PranaX Corporation represents a significant investment in the company’s vision for the future of regenerative medicine. With his extensive expertise and innovative approach, there is optimism surrounding the company's ability to deliver advanced solutions that cater to physicians and patients alike. The journey ahead looks promising as PranaX continues to set new standards in the wellness and aesthetic medicine landscape.